Delivery Order SPE2DX22D0010-SPE2D824FDV86
Award Date
11/30/23
Potential Completion Date
12/1/23
Potential Value
$15K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,122.91, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Vyvanse capsules, a specialty medication, and has an ultimate completion date of February 9, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award, valued at $1,121.24, was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The delivery order contract is for the supply of Vyvanse 50 mg capsules. It is a firm-fixed-price contract with an ultimate completion date of April 28, 2023. The contract was awarded on a full and open competition basis, with no set-aside designation. Amerisourcebergen Drug Corp holds a larger...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $6,667.23 award is for the supply of Vyvanse 50 mg capsules, a prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,461.21, is a delivery order for the delivery of 4,563,773,922 units of the medication Vyvanse 40 mg capsule. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides $1,841.30 for the delivery of Vyvanse 30 mg capsules to support the Defense Logistics Agency (DLA) Troop Support Medical. The award, with an ultimate completion date of April 24, 2023, is structured as a firm fixed-price Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,114.91 delivery order is for Vyvanse capsules, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 17, 2023 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp maintains a $999,999,999...
This federal contract award, with an ID of SPE2DX22D0010/SPE2D824FFU96, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,757.79 firm-fixed-price delivery order is for the supply of Vyvanse 30mg capsules. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,337.89 firm fixed-price delivery order is for the supply of 4,563,447,787 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of January 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,950.42 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the supply of Vyvanse 50 mg capsules in 100-count packages. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,008.89 firm-fixed-price delivery order is for the supply of Vyvanse 40 mg capsules. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC enables the efficient procurement of a...